“Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days,” Paul said during a press conference.
Hours after Delhi Chief Minister Arvind Kejriwal stated that the new COVID variant detected in Singapore is “deadly for children” and may bring in third wave of the disease in the country, Paul reassured that children will not get serious COVID-19 infection, adding that the situation is being closely monitored and reports referring to the variant are being examined.
Category:
Pandemic
Latest
India’s virus cases lower but WHO expert says positive tests ominously high
Even with a downturn over the past few days, experts said there was no certainty that infections had peaked, with alarm growing both at home and abroad over the new more contagious B.1.617 variant taking hold.
“There are still many parts of the country which have not yet experienced the peak, they are still going up,” World Health Organization Chief Scientist Soumya Swaminathan was quoted as saying in the Hindu newspaper.
Insurance for safeguarding employee value:Lloyd’s report
COVID-19 has exacerbated many of the risks involving human capital value. With the pandemic impacting the entire workforce globally, and many organisations still operating under a remote working model, the value of employees in achieving productivity is vital for business continuity. It is becoming increasingly apparent that talent attraction and retention, and employee wellbeing are not just intrinsically linked, they also have a direct impact on business performance.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.